FE
45
-3
SYK
73
5
AME
75
6
UPS
41
-2
SRE
69
-2
WMB
70
-2
RIG
46
-8
SE
65
11
FSLR
40
-3
ALLE
50
-3
HCA
53
-2
KMI
73
-2
BWA
55
2
COP
54
-2
WAT
65
4
AA
38
-18
NEE
50
-2
AIV
62
-2
CMA
62
-5
LB
67
15
FE
45
-3
SYK
73
5
AME
75
6
UPS
41
-2
SRE
69
-2
WMB
70
-2
RIG
46
-8
SE
65
11
FSLR
40
-3
ALLE
50
-3
HCA
53
-2
KMI
73
-2
BWA
55
2
COP
54
-2
WAT
65
4
AA
38
-18
NEE
50
-2
AIV
62
-2
CMA
62
-5
LB
67
15
Financhill
Back

Bicycle Therapeutics PLC Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Sell
21

BCYC
Bicycle Therapeutics PLC

Last Price:
23.13
Seasonality Move:
20.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Bicycle Therapeutics PLC Price Quote

$23.13
-0.27 (-1.15%)
(Updated: November 13, 2024 at 5:55 PM ET)

Bicycle Therapeutics PLC Key Stats

Sell
21
Bicycle Therapeutics PLC (BCYC) is a Sell
Day range:
$23.21 - $24.26
52-week range:
$13.07 - $28.67
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
32.67
P/B ratio:
1.94%
Volume:
112K
Avg. volume:
460.6K
1-year change:
76.07%
Market cap:
$1.6B
Revenue:
$27M
EPS:
$-3.29

How Much Does Bicycle Therapeutics PLC Make?

Is Bicycle Therapeutics PLC Growing As A Company?

Bicycle Therapeutics PLC Stock Price Performance

What Is Bicycle Therapeutics PLC 52-Week High & Low?

Bicycle Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicycle Therapeutics PLC?

Is Bicycle Therapeutics PLC Cash Flow Positive?

  • What Is BCYC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$202.6M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $519.9M
  • What Is Bicycle Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$918K

Bicycle Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    BCYC return on invested capital is -27.99%
  • What Is Bicycle Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -21.68%
  • What Is BCYC Return On Equity?
    ROE is a measure of profitability and is -29.19%

Bicycle Therapeutics PLC Earnings Date & Stock Price

Bicycle Therapeutics PLC Competitors

Bicycle Therapeutics PLC Dividend Yield

Bicycle Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.46%
Revenue: -50% -61.8%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 37.82
Upside from Last Price: 61.62%

Major Shareholders

  • How many BCYC shares are owned by institutional investors?
    55.2M BCYC shares are owned by institutional investors
  • How many BCYC shares are owned by insiders?
    1.1M BCYC shares are owned by insiders